Anemia in Cardiac Surgery - Can Something Bad Get Worse?

Abstract Introduction: Anemia and blood transfusion are risk factors for morbidity/mortality in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). The objective of this study is to analyze the association of blood transfusion with morbidity/mortality in patients undergoing coronary artery bypass grafting (CABG) under CPB in the state of São Paulo, Brazil. Methods: This is a retrospective analysis using the State of São Paulo Registry of Cardiovascular Surgery from November 2013 to August 2014. Blood transfusion was only considered during surgery or within six hours after surgery. Anemia was defined as hematocrit ≤ 37.5%. Patients < 18 years old were excluded. The sample was divided in four groups - Group I (851, no anemia), Group II (200, anemia without blood transfusion), Group III (181, no anemia and transfusion), and Group IV (258, anemia and transfusion). Results: A total of 1,490 patients were included; 639 (42.9%) were anemic and 439 (29.5%) underwent blood transfusion. Group II showed lower composite morbidity (odds ratio [OR] −0.05; confidence interval [CI] −0.27-0.17; P=0.81) than Group III (OR 0.41; CI 0.23-0.59; P=0.018) or Group IV (OR 0.54; CI 0.31-0.77; P=0.016). Group III was at greater risk of mortality (OR 0.73; CI 0.43-1.03; P=0.02) than Group II, which was exposed only to anemia (OR −0.13; CI −0.55-0.29; P=0.75), or Group IV (OR 0.29; CI −0.13-0.71; P=0.539). Conclusion: Anemia in patients undergoing CABG with CPB is bad, but blood transfusion can be worse, increasing at least 50% the risk for mortality and/or morbidity.

Saved in:
Bibliographic Details
Main Authors: Faria,Leandro Batisti de, Mejia,Omar Vilca, Miana,Leonardo Augusto, Lisboa,Luiz Augusto Ferreira, Manuel,Valdano, Jatene,Marcelo B., Jatene,Fabio B.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Cirurgia Cardiovascular 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382021000200165
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0102-76382021000200165
record_format ojs
spelling oai:scielo:S0102-763820210002001652021-05-05Anemia in Cardiac Surgery - Can Something Bad Get Worse?Faria,Leandro Batisti deMejia,Omar VilcaMiana,Leonardo AugustoLisboa,Luiz Augusto FerreiraManuel,ValdanoJatene,Marcelo B.Jatene,Fabio B. Anemia Cardiac Surgical Procedures Blood Transfusion Hematocrit Cardiopulmonary Bypass Risk Factors Abstract Introduction: Anemia and blood transfusion are risk factors for morbidity/mortality in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). The objective of this study is to analyze the association of blood transfusion with morbidity/mortality in patients undergoing coronary artery bypass grafting (CABG) under CPB in the state of São Paulo, Brazil. Methods: This is a retrospective analysis using the State of São Paulo Registry of Cardiovascular Surgery from November 2013 to August 2014. Blood transfusion was only considered during surgery or within six hours after surgery. Anemia was defined as hematocrit ≤ 37.5%. Patients < 18 years old were excluded. The sample was divided in four groups - Group I (851, no anemia), Group II (200, anemia without blood transfusion), Group III (181, no anemia and transfusion), and Group IV (258, anemia and transfusion). Results: A total of 1,490 patients were included; 639 (42.9%) were anemic and 439 (29.5%) underwent blood transfusion. Group II showed lower composite morbidity (odds ratio [OR] −0.05; confidence interval [CI] −0.27-0.17; P=0.81) than Group III (OR 0.41; CI 0.23-0.59; P=0.018) or Group IV (OR 0.54; CI 0.31-0.77; P=0.016). Group III was at greater risk of mortality (OR 0.73; CI 0.43-1.03; P=0.02) than Group II, which was exposed only to anemia (OR −0.13; CI −0.55-0.29; P=0.75), or Group IV (OR 0.29; CI −0.13-0.71; P=0.539). Conclusion: Anemia in patients undergoing CABG with CPB is bad, but blood transfusion can be worse, increasing at least 50% the risk for mortality and/or morbidity.info:eu-repo/semantics/openAccessSociedade Brasileira de Cirurgia CardiovascularBrazilian Journal of Cardiovascular Surgery v.36 n.2 20212021-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382021000200165en10.21470/1678-9741-2020-0304
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Faria,Leandro Batisti de
Mejia,Omar Vilca
Miana,Leonardo Augusto
Lisboa,Luiz Augusto Ferreira
Manuel,Valdano
Jatene,Marcelo B.
Jatene,Fabio B.
spellingShingle Faria,Leandro Batisti de
Mejia,Omar Vilca
Miana,Leonardo Augusto
Lisboa,Luiz Augusto Ferreira
Manuel,Valdano
Jatene,Marcelo B.
Jatene,Fabio B.
Anemia in Cardiac Surgery - Can Something Bad Get Worse?
author_facet Faria,Leandro Batisti de
Mejia,Omar Vilca
Miana,Leonardo Augusto
Lisboa,Luiz Augusto Ferreira
Manuel,Valdano
Jatene,Marcelo B.
Jatene,Fabio B.
author_sort Faria,Leandro Batisti de
title Anemia in Cardiac Surgery - Can Something Bad Get Worse?
title_short Anemia in Cardiac Surgery - Can Something Bad Get Worse?
title_full Anemia in Cardiac Surgery - Can Something Bad Get Worse?
title_fullStr Anemia in Cardiac Surgery - Can Something Bad Get Worse?
title_full_unstemmed Anemia in Cardiac Surgery - Can Something Bad Get Worse?
title_sort anemia in cardiac surgery - can something bad get worse?
description Abstract Introduction: Anemia and blood transfusion are risk factors for morbidity/mortality in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). The objective of this study is to analyze the association of blood transfusion with morbidity/mortality in patients undergoing coronary artery bypass grafting (CABG) under CPB in the state of São Paulo, Brazil. Methods: This is a retrospective analysis using the State of São Paulo Registry of Cardiovascular Surgery from November 2013 to August 2014. Blood transfusion was only considered during surgery or within six hours after surgery. Anemia was defined as hematocrit ≤ 37.5%. Patients < 18 years old were excluded. The sample was divided in four groups - Group I (851, no anemia), Group II (200, anemia without blood transfusion), Group III (181, no anemia and transfusion), and Group IV (258, anemia and transfusion). Results: A total of 1,490 patients were included; 639 (42.9%) were anemic and 439 (29.5%) underwent blood transfusion. Group II showed lower composite morbidity (odds ratio [OR] −0.05; confidence interval [CI] −0.27-0.17; P=0.81) than Group III (OR 0.41; CI 0.23-0.59; P=0.018) or Group IV (OR 0.54; CI 0.31-0.77; P=0.016). Group III was at greater risk of mortality (OR 0.73; CI 0.43-1.03; P=0.02) than Group II, which was exposed only to anemia (OR −0.13; CI −0.55-0.29; P=0.75), or Group IV (OR 0.29; CI −0.13-0.71; P=0.539). Conclusion: Anemia in patients undergoing CABG with CPB is bad, but blood transfusion can be worse, increasing at least 50% the risk for mortality and/or morbidity.
publisher Sociedade Brasileira de Cirurgia Cardiovascular
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382021000200165
work_keys_str_mv AT farialeandrobatistide anemiaincardiacsurgerycansomethingbadgetworse
AT mejiaomarvilca anemiaincardiacsurgerycansomethingbadgetworse
AT mianaleonardoaugusto anemiaincardiacsurgerycansomethingbadgetworse
AT lisboaluizaugustoferreira anemiaincardiacsurgerycansomethingbadgetworse
AT manuelvaldano anemiaincardiacsurgerycansomethingbadgetworse
AT jatenemarcelob anemiaincardiacsurgerycansomethingbadgetworse
AT jatenefabiob anemiaincardiacsurgerycansomethingbadgetworse
_version_ 1756429608592343040